---
created: '2026-02-08T19:29:31.657604Z'
description: '...'
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/gene/stat3/
slug: stat3
tags:
- gene
- inflammation
- immune_system
- cancer_biology
- imported
- primekg
title: STAT3
type: gene
updated: '2026-02-08T19:29:31.657604Z'
---

# "STAT3"

## Overview

**STAT3** (Signal Transducer and Activator of Transcription 3) is a member of the STAT protein family. It acts as both a cytoplasmic signaling messenger and a nuclear transcription factor.

Upon phosphorylation by JAK kinases (in response to cytokines like **IL-6**) or growth factor receptors, STAT3 dimerizes, translocates to the nucleus, and drives the expression of genes involved in cell survival, proliferation, and immune suppression.

## Biological Functions

### 1. Inflammation and Immunity
- **Acute Phase Response:** Drives the liver's production of acute-phase proteins (e.g., CRP) during inflammation.
- **Th17 Differentiation:** Essential for the development of Th17 helper T-cells, crucial for fighting fungal infections.
- **Immune Suppression:** In the tumor microenvironment, STAT3 inhibits the activity of dendritic cells and promotes regulatory T-cells (Tregs), helping tumors evade the immune system.

### 2. Cell Survival
- Upregulates anti-apoptotic genes (like *BCL2*, *BCL-XL*, *MCL1*), preventing cell death.

## Clinical Significance

- **Cancer:** STAT3 is constitutively activated (always "on") in diverse cancers (breast, prostate, melanoma, leukemia). It drives tumor growth, metastasis, and drug resistance.
- **Hyper-IgE Syndrome (Job's Syndrome):** Caused by dominant-negative mutations in STAT3. Characterized by eczema, recurrent staphylococcal lung infections, and extremely high IgE levels due to Th17 deficiency.
- **Autoimmunity:** Gain-of-function mutations lead to early-onset autoimmunity.

## Relationships

ENCODES::[[STAT3 Protein]]
ACTIVATED_BY::[[IL-6]] - Primary cytokine activator
ACTIVATED_BY::[[JAK2]] - Upstream kinase
ACTIVATED_BY::[[EGFR]]
PARTICIPATES_IN_PATHWAY::[[JAK-STAT Pathway]]
REGULATES::[[Inflammation]]
REGULATES::[[Th17 Cells]]
ASSOCIATED_WITH_CONDITION::[[Cancer]] - Promotes survival/metastasis
ASSOCIATED_WITH_CONDITION::[[Hyper-IgE Syndrome]] - Loss of function
ASSOCIATED_WITH_CONDITION::[[Psoriasis]] - Driven by Th17/STAT3 axis
TARGETS::[[BCL2]] - Anti-apoptotic gene
TARGETS::[[VEGF]] - Angiogenesis gene

## References

- Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736-46.
- Holland, S. M., et al. (2007). STAT3 mutations in the hyper-IgE syndrome. New England Journal of Medicine, 357(16), 1608-1619.